Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by PLITheOneon Dec 13, 2021 12:17pm
145 Views
Post# 34225380

RE:RE:they are selling their shares

RE:RE:they are selling their sharesLiminal has now eliminated all revenue generating products and gave away, actually paid to give away, their new approved drug to focus on the small molecule that would take several years to develop at substantial cost. There are many reasons that they shelved IVIG. Not only to underhandedly screw investors but because it was a commodity that could be developed and commercialized in a relatively short period. Why would they do that when your plan is to deep six the company? Everything they have done has been intentional to destroy this company!
Get informed and you can see why this stock has gone down since Thomvest put their plan in place in 2018.


stockbuphoon wrote:

Edrose, they are wiping out all these investors and the $100M that they got from priority review voucher. All part of the "we were fooled, too" plan including Management asking their R&D team that balain mentioned if they had any ideas on what drug indication to work on... 

 

edrose wrote: unfortunetly no assets left in this company only thomvest will benefit retail investors got wiped out april 2019

 

 



<< Previous
Bullboard Posts
Next >>